ArticleOncology reports2017

MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis.

Lixia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.